CClinicalTrials.gg
CompletedNCT00275769Updated Dec 11, 2008

CAPTURE - Complete Automatic Pacing Threshold Utilization Recorded by EnPulse

An interventional study of Pacemaker in Arrhythmia and Bradycardia, sponsored by Medtronic Cardiac Rhythm and Heart Failure. Completed at 57 sites in 2 countries. Per ClinicalTrials.gov, last updated 2008-12-11.

Sponsored by Medtronic Cardiac Rhythm and Heart Failure · Not applicable and Interventional

Phase
Not applicable
Study type
Interventional
Enrollment
860
Allocation
Randomized
Sex
All
01

Study summary

This study compares the pacemaker's automatic pacing threshold measurements to the manual measurements conducted by a health care provider.

Read the detailed description

The purpose(s) of the study is (are) to evaluate several features available in EnPulse Series pacemaker and report the long term benefit of Atrial Capture Management (ACM) and Ventricular Capture Management (VCM) as demonstrated by accuracy in comparison with manual measurements and variability of ACM and VCM thresholds.

In addition, an evaluation of the timesaving and qualitative benefits of the device feature known as Quick Look II (the computer interface screen of the device programmer) will be measured through the use of a questionnaire completed by the health care professionals involved in patient follow-up care.

This is a one-to-one randomized, multicenter, prospective study in which patients receiving new EnPulse pacemaker implants will be randomized to each of three study arms, 1) routine manual follow-up and follow-up using the automatic features; 2) ACM diagnostics detail on or VCM diagnostics detail on; 3) PMOP on / off or PMOP off / on (6 month cycle).

02

Conditions studied

  • Arrhythmia
  • Bradycardia

Keywords

  • Arrhythmia
  • Bradycardia
  • Cardiac Pacemaker Artificial
03

In context

Arrhythmias, Cardiac

885 studies on the registry are indexed under Arrhythmias, Cardiac; 235 are open to participants now.

This study's enrollment of 860 is above the median of 99 across 429 interventional studies indexed under Arrhythmias, Cardiac.

Browse Arrhythmias, Cardiac studies →

Lead sponsor

Medtronic Cardiac Rhythm and Heart Failure is the lead sponsor of 239 studies on the registry; 6 are open to participants now.

Of its 19 completed or terminated interventional studies of FDA-regulated products, 17 (89%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patients that meet ACC/AHA/NASPE 2002 class I or II dual chamber pacing indications (intended for a Pacing Mode programmed to DDD or DDDR)

Exclusion criteria

Exclusion Criteria:

  • Patient with mechanical tricuspid heart valves
  • Patients with medical conditions that preclude the testing required by the protocol or limit study participation
05

Study design

Phase
Not applicable
Allocation
Randomized
Intervention model
Factorial assignment
Masking
None (open label)
Enrollment
860 participants

Interventions

  • DevicePacemaker
06

What researchers measure

Primary outcomes

  1. The automatic device features Atrial Capture Management and Ventricular Capture Management measure pacing thresholds and is compared to manual pacing thresholds observed at the 6 month follow-up visit

Secondary outcomes

  1. Observe the variability of multiple pacing thresholds measured with ACM and VCM

  2. Observe visit time differences using automatic measurements versus traditional follow-up

  3. Observe the effects of Post Mode Switch Overdrive Pacing (PMOP) on AT/AF burden.

07

Study locations

57 sites
  • Anchorage, Alabama, United States
  • Mobil, Alabama, United States
  • Fullerton, California, United States
  • Oceanside, California, United States
  • Redondo Beach, California, United States
  • Stanford, California, United States
  • Colorado Springs, Colorado, United States
  • Washington, District of Columbia, United States
  • Brandon, Florida, United States
  • Daytona Beach, Florida, United States
  • Orlando, Florida, United States
  • Sarasota, Florida, United States
  • Athens, Georgia, United States
  • Gainsville, Georgia, United States
  • Chicago, Illinois, United States
  • Peoria, Illinois, United States
  • Des Moines, Iowa, United States
  • Kansas City, Kansas, United States
  • Worcester, Maine, United States
  • Burlington, Massachusetts, United States
  • Petoskey, Michigan, United States
  • St. Paul, Minnesota, United States
  • Jackson, Mississippi, United States
  • Columbia, Missouri, United States
  • St. Louis, Missouri, United States
  • Flemington, New Jersey, United States
  • Newark, New Jersey, United States
  • Paramus, New Jersey, United States
  • Albuquerque, New Mexico, United States
  • Fayetteville, New York, United States
  • New York, New York, United States
  • High Point, North Carolina, United States
  • Akron, Ohio, United States
  • Cleveland, Ohio, United States
  • Steubenville, Ohio, United States
  • Lawton, Oklahoma, United States
  • Tualatin, Oregon, United States
  • Altoona, Pennsylvania, United States
  • Philadelphia, Pennsylvania, United States
  • Pawtucket, Rhode Island, United States
  • Columbia, South Carolina, United States
  • Greenville, South Carolina, United States
  • Sioux Falls, South Dakota, United States
  • Knoxville, Tennessee, United States
  • Oak Ridge, Tennessee, United States
  • Forth Worth, Texas, United States
  • Houston, Texas, United States
  • Richmond, Virginia, United States
  • Spokane, Washington, United States
  • Charleston, West Virginia, United States
  • Wausau, Wisconsin, United States
  • North Vancouver, British Columbia, Canada
  • Kitchener, Ontario, Canada
  • Toronto, Ontario, Canada
  • Laval, Quebec, Canada
  • Saskatoon, Saskatchewan, Canada
  • Quebec, Canada
08

References and documents

Publications

  • Rosenthal LS, Mester S, Rakovec P, Penaranda JB, Sherman JR, Sheldon TJ, Zeng C, Wang P; CAPTURE Trial Investigators. Factors influencing pacemaker generator longevity: results from the complete automatic pacing threshold utilization recorded in the CAPTURE Trial. Pacing Clin Electrophysiol. 2010 Aug;33(8):1020-30. doi: 10.1111/j.1540-8159.2010.02809.x. Epub 2010 Jun 2. PubMed 20545869 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 11, 2008, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT00275769
Lead sponsor
Medtronic Cardiac Rhythm and Heart Failure
Collaborators
Medtronic
First posted
Jan 12, 2006
Start date
Mar 2004
Primary completion
Sep 2006
Completion
Sep 2006
Last update
Dec 11, 2008

Study contacts

Stephen W. Mester, MD
principal investigator · Tampa General Hospital
Lawrence S. Rosenthal, MD
principal investigator · UMASS Memorial Medical Center
Raymond Gendreau, MD
principal investigator · Cite di la Sante de Laval
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2008. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion